Healthcare professionals consume content differently than typical B2B buyers. They need clinical evidence, peer validation, and regulatory clarity – not marketing copy about innovation and efficiency.
The Problem
Clinical audiences reject marketing-driven content
A clinician can spot content written by a marketing team versus a clinical author within a paragraph. Generic health tech copy about 'improving patient outcomes' gets skipped because it lacks specificity – no citation, no workflow detail, no acknowledgment of how a clinic actually operates. Content that doesn't clear that bar doesn't just underperform, it damages credibility with the exact stakeholders who need to trust the product before a health system will pilot it.
Regulatory and compliance content is poorly executed
Digital health companies have to write about HIPAA, FDA classification (510(k), De Novo, or software-as-a-medical-device pathways), and clinical evidence requirements, and most either avoid the topic or bury it in dense legal language nobody reads. Buyers on the health system side need a plain explanation of what a regulatory status actually means for procurement and liability. Few vendors write that content clearly, which leaves compliance officers to piece it together themselves – and slows every deal.
Clinical evidence and research go unused
Most digital health companies are sitting on real material – pilot outcomes, published studies, research partnerships – and never turn it into content. Clinicians make adoption decisions the way they were trained to: on evidence, not adjectives. Without that evidence surfaced in the content itself, a clinical champion has nothing to bring back to their committee, and the deal stalls at the exact point where it should be closing.
Multi-stakeholder content needs go unaddressed
A digital health sale runs through clinicians, IT/security, administrators, and often a compliance officer, each of whom needs a different artifact at a different stage – a clinician wants outcomes data, IT wants an integration and security brief, an administrator wants a cost and workflow case. Most companies write one asset for one audience and expect it to carry the whole committee. It doesn't, and the gap shows up as a stalled deal nobody can quite explain.
How We Help
We start with a content and stakeholder audit: what you've published, who's actually reading it, and where the drop-off happens between a clinician's first click and a signed pilot. This means pulling engagement data across your current content, mapping it against your buying committee (clinician, IT/security, administrator, compliance), and flagging which stakeholder has nothing written for them at all. Most digital health companies find at least one committee member with zero dedicated content – that's usually the fastest fix.
Strategy comes next: a content framework built around the actual buying committee rather than a single persona. That means a clinical evidence track, a regulatory/compliance track written in plain language, and an implementation track for IT and operations – each feeding the same sales cycle from a different angle. The goal is content a clinician would forward to a colleague without editing it first, because it reads like it was written by someone who understands the workflow, not someone selling into it.
Production is where this gets specific: evidence-based clinical pieces grounded in your actual pilot data or published research (never invented), regulatory explainers that translate FDA and HIPAA status into procurement-relevant language, and implementation guides written for IT and clinical operations. We work directly with your clinical and medical affairs team on every piece so nothing published contradicts how your product actually performs in the field – that review step is non-negotiable in healthcare.
Once content is live, we track engagement by stakeholder type, not just aggregate traffic – which pieces a clinician shares, which a compliance officer downloads before a call, which correlates with deals actually moving. That data drives the next quarter's content plan and keeps the [creative](/services/creative/) production process pointed at what's converting, not just what's easy to write.
What we deliver
- Content and stakeholder audit – maps existing assets against your buying committee and flags coverage gaps
- Multi-stakeholder content framework – clinical, regulatory, and implementation tracks built for the actual sales cycle
- Evidence-based clinical content and regulatory explainers – grounded in your real data, reviewed by your clinical team
- Implementation guides and case studies – written for IT, operations, and administrators, not just clinicians
- Stakeholder-level performance tracking – which content moves which committee member, updated quarterly
A digital health deal usually stalls with one committee member who has nothing written for them – not the clinician, who's already convinced, but the compliance officer or IT lead with no plain-language artifact to bring to their own review. Trust comes through teaching each stakeholder in their own terms, not one asset stretched to cover all of them.
Our Methodology
The first 30 days go into understanding how your specific buyers – clinicians, IT, compliance, administrators – actually consume information: which journals or forums they trust, what a compliance officer needs before they'll sign off, what an IT lead needs to see before a security review clears the vendor. We map that against your current content to find where the buying committee has nothing to read.
Days 31-60 are production: building out the clinical, regulatory, and implementation tracks identified in the audit, with every clinical claim reviewed against your actual data before it publishes. This is where most of the work happens, because writing credible clinical and regulatory content takes real coordination with your medical affairs team, not a generic content calendar.
The final 30 days set up distribution and measurement – getting content in front of the right stakeholder through the channel they actually use (clinical newsletters, LinkedIn for administrators, direct outreach for compliance), then tracking which pieces correlate with deals moving instead of just page views. By day 90 you have a repeatable content process, not a one-time sprint that goes stale.
How We Work
We open with a two-week content and stakeholder audit – reviewing existing assets, pulling engagement data, and interviewing a few clinical customers and sales reps about what content actually gets used in a sales conversation. Weeks three and four turn that into a content strategy and editorial calendar built around your buying committee, not a generic B2B funnel.
Our team on this engagement includes a content strategist with healthcare market experience, a medical writer who can produce clinically credible copy, and a strategist who tracks stakeholder-level engagement. From your side, we need access to clinical team members for review, sales feedback on what's landing, and whatever real evidence – pilot data, published research – you're willing to put in front of buyers.
We run on monthly planning cycles with content shipping every two weeks, and you get a performance report each month broken down by stakeholder type, not just blended traffic numbers. Companies typically see engagement move within 6-8 weeks of the first pieces going live, and a measurable shift in lead quality by weeks 12-16. Initial engagements run 4-6 months, with most clients extending once the content pipeline is producing on its own.
- Stakeholder-specific engagement – measurable movement from clinicians, compliance, and IT, not just aggregate traffic
- Faster committee sign-off – fewer deals stalling on a missing regulatory or implementation artifact
- Clinical credibility – content clinicians actually reference and share
- A repeatable content system – not a one-time content sprint that goes stale after the engagement ends
If your digital health company needs content marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a content marketing engagement cost for digital health companies?
Engagements typically run $15K-$25K per month depending on content volume and how much clinical/regulatory review is required. That covers strategy, medical writing, and distribution – not just a blog calendar. Against a healthcare content manager hire (often $130K+ base, plus a medical writer on top), you get the same specialized skill set without the ramp time. Most companies see it pay for itself once one stalled deal in the pipeline starts moving again.
How long before we see results from a healthcare content marketing engagement?
Engagement metrics – shares, downloads, time on clinical content – typically move within 6-8 weeks of the first pieces publishing. Lead quality and sales conversation improvement usually show up by weeks 12-16, once the regulatory and implementation content starts closing gaps in the buying committee. Durable thought-leadership credibility builds over 6-12 months, but the early signal comes much faster.
How does the content marketing team integrate with our existing clinical staff?
Every clinical claim gets reviewed by your medical affairs or clinical team before it publishes – we don't put anything in front of a healthcare audience that your own clinicians haven't signed off on. Our medical writer works directly with your subject matter experts rather than interviewing them once and writing from notes. We fit into whatever review process you already have rather than asking you to build a new one.
What makes Winston Francois different from a traditional healthcare content agency?
Most healthcare content agencies are built for patient education or consumer health marketing, which is a different discipline from B2B content aimed at a clinical and administrative buying committee. We focus specifically on the digital health sales cycle – what a clinician, a compliance officer, and an IT lead each need to see before a deal moves. That's a narrower, more operational focus than general healthcare content work.
How do you measure ROI from a healthcare content marketing engagement?
We track engagement by stakeholder type – which content a clinician shares, which a compliance officer pulls before a call, which correlates with deals actually advancing – rather than blended pageview counts. The real measure is whether stalled deals start moving once the missing content gap gets filled. Most clients see a measurable shift in lead quality within 60-90 days.
What type of digital health company is the right fit for this service?
Companies with a real clinical value proposition but a stalled sales cycle because the buying committee doesn't have what it needs to say yes – typically Series A-B with meaningful ARR and at least one pilot or evidence source to draw on. If you have real clinical data but nothing built to communicate it to compliance or IT, that's usually the clearest fit. The first step is auditing what you have and where the committee gap actually is.
